APA (7th ed.) Citation

Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., . . . Ryan, D. H. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England journal of medicine, 389(24), 2221-2232. https://doi.org/10.1056/NEJMoa2307563

Chicago Style (17th ed.) Citation

Lincoff, A. Michael, et al. "Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes." The New England Journal of Medicine 389, no. 24 (2023): 2221-2232. https://doi.org/10.1056/NEJMoa2307563.

MLA (9th ed.) Citation

Lincoff, A. Michael, et al. "Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes." The New England Journal of Medicine, vol. 389, no. 24, 2023, pp. 2221-2232, https://doi.org/10.1056/NEJMoa2307563.